skip to main content
Result Number Material Type Add to My Shelf Action Record Details and Options
1
30 CD56 bright natural killer cells primed by innate immune cytokines dominate the immune response stimulated by BCG to non-muscle invasive bladder cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

30 CD56 bright natural killer cells primed by innate immune cytokines dominate the immune response stimulated by BCG to non-muscle invasive bladder cancer

Garcia – Cuesta, E.M ; Esteso, G ; Ashiru, O ; Rodríguez-Alcázar, J ; Alvarez-Maestro, M ; Lopez-Cobo, S ; Linares Espinos, E ; Reyburn, H ; Linares, A ; Ho, M ; Martinez-Piñeiro, L ; Valés-Gómez, M

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e30-e30

Texto completo disponível

2
942 - The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG
Material Type:
Artigo
Adicionar ao Meu Espaço

942 - The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG

Alvarez Maestro, M.E. ; Ashiru, O. ; Esteso, G. ; Garcia-Cuesta, E.M. ; Lopez-Cobo, S. ; Alvarez-Maestro, M. ; Linares, A. ; Leibar, A. ; Gomez-Rivas, J. ; Ho, M.M. ; Martinez-Pineiro, L. ; Valés-Gómez, M.

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e1345-e1345

Elsevier B.V

Texto completo disponível

3
The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG
Material Type:
Artigo
Adicionar ao Meu Espaço

The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG

Alvarez Maestro, M.E. ; Ashiru, O. ; Esteso, G. ; Garcia-Cuesta, E.M. ; Lopez-Cobo, S. ; Alvarez-Maestro, M. ; Linares, A. ; Leibar, A. ; Gomez-Rivas, J. ; Ho, M.M. ; Martinez-Pineiro, L. ; Valés-Gómez, M.

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e1345

Texto completo disponível

4
402 Characterization of Natural Killer cell response to BCG in non-muscle invasive bladder cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

402 Characterization of Natural Killer cell response to BCG in non-muscle invasive bladder cancer

Garcia-Cuesta, E ; Esteso, G ; Alvarez-Maestro, M ; Lopez-Cobo, S ; Linares, A ; Reyburn, H ; Martinez-Piñeiro, L ; Valés-Gómez, M

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e402-e402

Elsevier B.V

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até

Neste Assunto:

  1. Urology

Buscando em bases de dados remotas. Favor aguardar.